Insider · CIK 0002113223
Hendrik Peter Scholl
Files at BLTE (BELITE BIO, INC). First filing Jun 17, 2026, latest Oct 5, 2026.
In brief
Hendrik Peter Scholl files SEC Form 4 as officer at BLTE (BELITE BIO, INC). Since Jun 17, 2026, Hendrik Peter Scholl has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.9M, the latest filed on Oct 5, 2026.
A track record needs three past buys with six months of prices behind them; Hendrik Peter Scholl has 0, so none is measured yet.
The newest scored trade: sold $83k of BLTE on Oct 1, 2026, filed Oct 5, 2026, scored 4 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $2.9M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BLTE: BELITE BIO, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 4Weak | BELITE BIO, INC | $83k 500 shares | -3% | +122% from low-16% from high | |
| 50Moderate | BLTEsell BELITE BIO, INC | $1.5M 10,000 shares | -40% | +157% from low-23% from high | |
| 50Moderate | BLTEsell BELITE BIO, INC | $1.4M 10,000 shares | -29% | +143% from low-27% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 1, 2026 | BLTE Belite Bio, Inc. | 4,000 0.01% of outstanding | $679k | Oct 1, 2026 | none |
| Jun 18, 2026 | BLTE Belite Bio, Inc. | 10,000 0.03% of outstanding | $1.5M | Jun 18, 2026 | $1.4M |
| Jun 16, 2026 | BLTE Belite Bio, Inc. | 10,000 0.03% of outstanding | $1.4M | Jun 16, 2026 | none |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -200 | $163.63 | $33k | 14,800 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -24 | $164.64 | $3,951 | 14,776 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -120 | $165.49 | $20k | 14,656 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -50 | $166.44 | $8,322 | 14,606 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -78 | $167.59 | $13k | 14,528 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -12 | $168.21 | $2,019 | 14,516 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -14 | $169.36 | $2,371 | 14,502 | 8 d ago |
| Oct 1, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd.10b5-1 | -2 | $170.02 | $340 | 14,500 | 8 d ago |
| Jun 18, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -96 | $143.90 | $14k | 24,904 | Jun 22, 2026 |
| Jun 18, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -3,748 | $144.66 | $542k | 21,156 | Jun 22, 2026 |
| Jun 18, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -4,861 | $145.43 | $707k | 16,295 | Jun 22, 2026 |
| Jun 18, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -1,199 | $146.24 | $175k | 15,096 | Jun 22, 2026 |
| Jun 18, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -96 | $147.11 | $14k | 15,000 | Jun 22, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -2,054 | $137.61 | $283k | 32,946 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -784 | $138.18 | $108k | 32,162 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -3,140 | $139.57 | $438k | 29,022 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -540 | $140.58 | $76k | 28,482 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -100 | $141.83 | $14k | 28,382 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -450 | $142.20 | $64k | 27,932 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -1,897 | $143.55 | $272k | 26,035 | Jun 17, 2026 |
| Jun 16, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary shareindirect: By Bioptima Ltd. | -1,035 | $145.02 | $150k | 25,000 | Jun 17, 2026 |
| Apr 21, 2026 | BLTE BELITE BIO, INC | JOther Stock Option (right to buy)derivativeindirect: By Bioptima Ltd. | +10,000 | $0.00 | $0 | 10,000 | Apr 23, 2026 |
Questions about Hendrik Peter Scholl
Answered from the filings on this page, as of the latest one.
Is Hendrik Peter Scholl buying or selling?
In the last 12 months Hendrik Peter Scholl reported 0 open-market buys worth $0 and 3 open-market sells worth $2.9M on SEC Form 4; the latest was sold $83k of BLTE on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Hendrik Peter Scholl's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hendrik Peter Scholl has 0.
Where does Hendrik Peter Scholl file Form 4?
Hendrik Peter Scholl has filed Form 4 at BLTE (BELITE BIO, INC) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.